BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Genetown

  Harbour BioMed Raises $102 Million to Support Development Programs

  The latest funding round came hard on the heels of $75 million the company raised in March, giving the company a total of $177 million raised in the first half of 2020.

  July 9, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  NIAID Creates Clinical Trials Network to Focus on COVID-19 Vaccines, Monoclonal Antibodies

  The National Institute of Allergy & Infectious Diseases (NIAID) has founded a new clinical trials network focused on enrolling volunteers in clinical trials for COVID-19 vaccines and monoclonal antibodies.

  July 9, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Biopharma Update on the Novel Coronavirus: July 10

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.

  July 9, 2020

   · 

  4 min read

   · 

  BioSpace Editorial Staff
• 

  Policy

  Good, But Not Good Enough: FDA Rejects Merck-Eisai Combo for Liver Cancer

  The U.S. Food and Drug Administration issued a Complete Response Letter to Merck and Eisai over their Lenvima and Keytruda combination for first-line treatment of unresectable hepatocellular carcinoma (HCC).

  July 9, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Alzheimer’s Drugs on Verge of Becoming Mainstream Medicine, but Early Intervention Still is Needed

  Diagnostics and therapeutics for Alzheimer’s disease are on the verge of becoming mainstream medicine. It’s about time, too.

  July 9, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  Kymera and Sanofi Enter Anti-Inflammatory Deal Worth More than $2 Billion

  They will focus on developing and commercializing protein degrader therapies that target IRAK4 in immune-inflammatory diseases, such and rheumatoid arthritis.

  July 9, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Beach

  Tranquis Launches with $30 Million and Novel Approach to Neurodegenerative Disorders

  San Mateo, Calif.-based Tranquis will initially focus its research on orphan diseases such as Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

  July 9, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  BioMidwest

  Research Roundup: COVID-19 Immunity, Stomach Acid Susceptibility and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  July 9, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Forbion Continues Funding Efforts, Raises $208M for More Investments

  Forbion, a European life sciences venture capital firm, announced today that it had closed its Forbion Growth Opportunities Fund at $208 million.

  July 9, 2020

   · 

  3 min read

   · 

  Krystle Vermes
• 

  Business

  BioSpace Movers & Shakers, July 10

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  July 9, 2020

   · 

  7 min read

   · 

  Alex Keown